Major Pharmaceuticals Recalls Thyroid Drugs for Underdosing
On July 13, Major Pharmaceuticals announced a voluntary recall of its levothyroxine sodium tablets. This action followed a determination by the Food and Drug Administration that the tablets were subpotent, indicating they provide a lower dosage of medication than what is stated on the label.
Key facts
- Major Pharmaceuticals recalled levothyroxine sodium tablets
- Recall initiated on July 13
- FDA determined pills were subpotent
- Subpotent means delivering less medication than labeled
Entities
Institutions
- Major Pharmaceuticals
- Food and Drug Administration
Sources
- Quartz —